OncoGenex Pharmaceuticals (NASDAQ:OGXI)
| CAPS Rating |
|
|---|---|
| Open | $14.35 |
| Previous Close | $14.48 |
| Daily Range | $14.09 - $14.58 |
| 52-Week Range | $8.63 - $18.99 |
| Market Cap | $138.69M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 35,837 |
| Average Daily Volume | 0 |
OGXI
VS S&P 500 (SPY)
How do you think OGXI will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OGXI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OGXI News and Commentary
- 5 Bargain-Bin Stocks for Holiday Shoppers – The Motley Fool
- Registration Effectiveness Orders Issued By The SEC – SmartMoney
- Immunogen's Drug In the Spotlight – Blog at The Motley Fool
- The Cancer Conference Trade: Picking Up Biotech Bargains – The Motley Fool
- Dendreon Increases Potential Output, More to Come – The Motley Fool
- Brakes Are Off at Dendreon – The Motley Fool
- Prostate Cancer Drug Roars Ahead – The Motley Fool
- OncoGenex (OGXI): Biotech Targets Cancer Treatments – BloggingStocks
- Medivation Shares Popped: What You Need to Know – The Motley Fool
- The Biggest Threat to Dendreon's Future – The Motley Fool
- Rebound Ideas: 15 Cash-Rich Companies Seeing Bullish Technical Divergence – SeekingAlpha
- To Partner or Not to Partner: That is the Question – SeekingAlpha
- BlacknGold Pharma Blogs - NBY – Blog at The Motley Fool
- OncoGenex Pharmaceuticals: Novel Products, Financial Flexibility – SeekingAlpha
- A Dendreon Killer? Not Yet. – The Motley Fool
- A Potential Blockbuster Roars Ahead – The Motley Fool
RSS Headlines
Fool UK
